These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1165 related articles for article (PubMed ID: 37496131)

  • 1. Tacrolimus and Cyclosporin Pharmacotherapy, Detection Methods, Cytochrome P450 Enzymes after Heart Transplantation.
    Tolou-Ghamari Z
    Cardiovasc Hematol Agents Med Chem; 2024; 22(2):106-113. PubMed ID: 37496131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered cytochrome p450 metabolism of calcineurin inhibitors: case report and review of the literature.
    Formea CM; Evans CG; Karlix JL
    Pharmacotherapy; 2005 Jul; 25(7):1021-9. PubMed ID: 16006281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B; Kubanek M; Malek I; Vymetalova Y; Hoskova L; Podzimkova M; Kautzner J
    J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
    Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C
    Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.
    Plosker GL; Foster RH
    Drugs; 2000 Feb; 59(2):323-89. PubMed ID: 10730553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive drugs in paediatric liver transplantation.
    van Mourik ID; Kelly DA
    Paediatr Drugs; 2001; 3(1):43-60. PubMed ID: 11220404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions.
    Kuypers DR
    Drugs Aging; 2009; 26(9):715-37. PubMed ID: 19728747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Drug Monitoring of Blood Sirolimus and Tacrolimus Concentrations for Polypharmacy Management in a Lymphangioleiomyomatosis Patient Taking Two Cytochrome P450 3A Inhibitors.
    Kumondai M; Kikuchi M; Mizuguchi A; Hayashi N; Ui M; Hirama T; Okada Y; Sato Y; Sato T; Maekawa M; Mano N
    Tohoku J Exp Med; 2023 May; 260(1):29-34. PubMed ID: 36858510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics.
    Iwasaki K
    Drug Metab Pharmacokinet; 2007 Oct; 22(5):328-35. PubMed ID: 17965516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs.
    Lytton SD; Berg U; Nemeth A; Ingelman-Sundberg M
    Clin Exp Immunol; 2002 Feb; 127(2):293-302. PubMed ID: 11876753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus Pharmacotherapy: Infectious Complications and Toxicity in Organ Transplant Recipients; An Updated Review.
    Tolou Ghamari Z; Palizban AA
    Curr Drug Res Rev; 2023 Dec; ():. PubMed ID: 38151846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Controversy in Transplantation: Tacrolimus Versus Cyclosporine in Statin Drug Interactions.
    Migliozzi DR; Asal NJ
    Ann Pharmacother; 2020 Feb; 54(2):171-177. PubMed ID: 31441337
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interaction between sildenafil and calcineurin inhibitors in renal transplant recipients with erectile dysfunction].
    Cofán F; Gutiérrez R; Beardo P; Campistol JM; Oppenheimer F; Alcover J
    Nefrologia; 2002; 22(5):470-6. PubMed ID: 12497749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy outcomes in female patients exposed to cyclosporin-based versus tacrolimus-based immunosuppressive regimens after liver/kidney transplantation: A systematic review and meta-analysis.
    Gong X; Li J; Yan J; Dai R; Liu L; Chen P; Chen X
    J Clin Pharm Ther; 2021 Jun; 46(3):744-753. PubMed ID: 33386628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.
    Staatz CE; Goodman LK; Tett SE
    Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-adjusted and dose/kg-adjusted concentrations of mycophenolic acid precursors reflect metabolic ratios of their metabolites in contrast with tacrolimus and cyclosporine.
    Hryniewiecka E; Żegarska J; Żochowska D; Samborowska E; Jaźwiec R; Kosieradzki M; Nazarewski S; Dadlez M; Pączek L
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31395739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus: a new immunosuppressive agent.
    Kelly PA; Burckart GJ; Venkataramanan R
    Am J Health Syst Pharm; 1995 Jul; 52(14):1521-35. PubMed ID: 7552894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine.
    Armstrong VW; Oellerich M
    Clin Biochem; 2001 Feb; 34(1):9-16. PubMed ID: 11239509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor.
    Sugiyama K; Tsukaguchi M; Toyama A; Satoh H; Saito K; Nakagawa Y; Takahashi K; Tanaka S; Onda K; Hirano T
    Exp Clin Transplant; 2014 Jun; 12(3):195-9. PubMed ID: 24907718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.